ANI Pharmaceuticals Inc (ANIP)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	18,779	13,381	-5,159	-26,327	-47,896	-67,789	-63,636	-62,819	-42,603	-22,102	-17,221	-15,451	-22,548	-23,748	-20,287	-1,366	6,094	16,359	17,501	13,693
Total assets	US$ in thousands	904,422	889,914	859,341	765,224	760,087	739,110	751,334	744,846	771,598	470,454	480,159	463,843	461,190	462,581	465,391	482,232	456,789	456,775	446,906	434,390
ROA		2.08%	1.50%	-0.60%	-3.44%	-6.30%	-9.17%	-8.47%	-8.43%	-5.52%	-4.70%	-3.59%	-3.33%	-4.89%	-5.13%	-4.36%	-0.28%	1.33%	3.58%	3.92%	3.15%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $18,779K ÷ $904,422K
= 2.08%

ANI Pharmaceuticals Inc has shown a fluctuating trend in its return on assets (ROA) over the past eight quarters. The ROA improved from negative values in Q4 2022 and Q1 2023 to positive values in Q2 2023 and Q3 2023, with the highest ROA recorded in Q4 2023 at 1.90%. This indicates that the company has been able to generate more profits relative to its total assets in the recent quarters. However, it is essential to monitor this metric consistently to assess the company's efficiency in utilizing its assets to generate profits effectively.